LINC01499

Across TCGA pan-cancer cohorts, LINC01499 RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated LINC01499 data layer.

The strongest signal is observed in kidney chromophobe (KICH), where higher LINC01499 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC01499 expression acts as an unfavorable survival marker, although some lineages such as OV show a favorable association.

KICH, LUAD, and UCS are the cancer types where LINC01499 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KICH	OS	Tertile	All	0.278	0.905	<.001	93	view →
LUAD	OS	Tertile	All	0.665	0.846	.001	75	view →
UCS	OS	Tertile	All	0.007	0.689	<.001	72	view →
LGG	OS	Tertile	All	0.156	0.530	<.001	36	view →
ACC	OS	Tertile	All	0.133	0.686	.004	36	view →
SARC	DFS	Tertile	All	0.104	0.404	.006	30	view →
ESCA	OS	Quartile	IV	0.095	0.597	.045	18	view →
READ	DFS	Tertile	All	0.163	0.566	.016	18	view →
STAD	DFS	Tertile	IV	0.083	0.379	.001	9	view →
OV	OS	Tertile	IV	1.000	0.589	.042	6	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

LINC01499–KICH (OS)

Open the KICH breakdown →